Home Recalls D-1082-2014
Class II · Moderate risk Terminated Initiated Dec 20, 2013 (13 years ago)
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.
What was recalled
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.
Recalling firm Watson Laboratories, Inc.-(Actavis) - Florida
NDC code 0591-0398-60
Origin FL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-1082-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Jan 27, 2026
Reason Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
Class III · Low risk Ongoing Dec 22, 2025
Reason Failed PH Specifications
Class II · Moderate risk Ongoing Jun 22, 2023
Reason Defective Delivery System
Class II · Moderate risk Terminated Mar 24, 2022
Reason CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability…
Class II · Moderate risk Terminated Mar 15, 2022
Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.